

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91323319 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.89262368 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.89262368 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.88947449 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.88817134 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.86634722 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.86634722 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.80786374 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.80786374 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 4.80467911 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73214809 |
| 12 | neurofilament cytoskeleton organization (GO:0060052) | 4.64184484 |
| 13 | detection of other organism (GO:0098543) | 4.57798042 |
| 14 | detection of bacterium (GO:0016045) | 4.57731551 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55125135 |
| 16 | regulation of DNA methylation (GO:0044030) | 4.52072034 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.49747336 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.49747336 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.49747336 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.49747336 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.49747336 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.49747336 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.45497734 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.33962186 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 4.33868587 |
| 26 | cysteine metabolic process (GO:0006534) | 4.32849599 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.30837287 |
| 28 | regulation of cholesterol homeostasis (GO:2000188) | 4.23964527 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.20344877 |
| 30 | urea metabolic process (GO:0019627) | 4.19806489 |
| 31 | urea cycle (GO:0000050) | 4.19806489 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.03840805 |
| 33 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.02508800 |
| 34 | protein carboxylation (GO:0018214) | 4.01501000 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.01501000 |
| 36 | kynurenine metabolic process (GO:0070189) | 4.01096153 |
| 37 | phospholipid efflux (GO:0033700) | 4.00695324 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.00241391 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.98745548 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 3.93520170 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.91441254 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.91441254 |
| 43 | tryptophan catabolic process (GO:0006569) | 3.91441254 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 3.89910002 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.89831275 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 3.88459113 |
| 47 | negative regulation of sterol transport (GO:0032372) | 3.88459113 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.85465079 |
| 49 | low-density lipoprotein particle clearance (GO:0034383) | 3.84643318 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 3.84414496 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.84055401 |
| 52 | glyoxylate metabolic process (GO:0046487) | 3.81971604 |
| 53 | bile acid biosynthetic process (GO:0006699) | 3.74590567 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 3.73686251 |
| 55 | detection of external biotic stimulus (GO:0098581) | 3.72965051 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.70033689 |
| 57 | tryptophan metabolic process (GO:0006568) | 3.69940576 |
| 58 | reverse cholesterol transport (GO:0043691) | 3.68186275 |
| 59 | lysine catabolic process (GO:0006554) | 3.66379349 |
| 60 | lysine metabolic process (GO:0006553) | 3.66379349 |
| 61 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.65833129 |
| 62 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.65833129 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.63502682 |
| 64 | regulation of protein activation cascade (GO:2000257) | 3.63401170 |
| 65 | triglyceride homeostasis (GO:0070328) | 3.60266257 |
| 66 | acylglycerol homeostasis (GO:0055090) | 3.60266257 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.59194392 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.58959598 |
| 69 | amino-acid betaine metabolic process (GO:0006577) | 3.58515460 |
| 70 | positive regulation of lipid catabolic process (GO:0050996) | 3.58050024 |
| 71 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.55674545 |
| 72 | response to peptidoglycan (GO:0032494) | 3.54710616 |
| 73 | bile acid metabolic process (GO:0008206) | 3.51714591 |
| 74 | phospholipid homeostasis (GO:0055091) | 3.50459313 |
| 75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.49662465 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 3.49662465 |
| 77 | macromolecular complex remodeling (GO:0034367) | 3.49662465 |
| 78 | serine family amino acid catabolic process (GO:0009071) | 3.48849974 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.46866248 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46492160 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46492160 |
| 82 | regulation of complement activation (GO:0030449) | 3.46158051 |
| 83 | regulation of fibrinolysis (GO:0051917) | 3.45490276 |
| 84 | bile acid and bile salt transport (GO:0015721) | 3.45292379 |
| 85 | cholesterol efflux (GO:0033344) | 3.41535480 |
| 86 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.40388551 |
| 87 | intestinal absorption (GO:0050892) | 3.38163176 |
| 88 | valine metabolic process (GO:0006573) | 3.37442946 |
| 89 | cholesterol homeostasis (GO:0042632) | 3.36869427 |
| 90 | protein-lipid complex assembly (GO:0065005) | 3.36628557 |
| 91 | sterol homeostasis (GO:0055092) | 3.33855787 |
| 92 | leukocyte aggregation (GO:0070486) | 3.32345909 |
| 93 | fatty acid beta-oxidation (GO:0006635) | 3.28681882 |
| 94 | ethanol oxidation (GO:0006069) | 3.26077711 |
| 95 | lipoprotein metabolic process (GO:0042157) | 3.24847298 |
| 96 | fatty acid oxidation (GO:0019395) | 3.23187717 |
| 97 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.22752753 |
| 98 | drug catabolic process (GO:0042737) | 3.21508130 |
| 99 | detection of biotic stimulus (GO:0009595) | 3.20185499 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 3.19728250 |
| 101 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19709114 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 3.19688448 |
| 103 | regulation of cholesterol storage (GO:0010885) | 3.16756310 |
| 104 | lipid oxidation (GO:0034440) | 3.16391635 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.15648671 |
| 106 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.15492516 |
| 107 | germinal center formation (GO:0002467) | 3.14092932 |
| 108 | aromatic amino acid family metabolic process (GO:0009072) | 3.13714482 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.13347418 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08854060 |
| 111 | detection of molecule of bacterial origin (GO:0032490) | 3.06690023 |
| 112 | fatty acid catabolic process (GO:0009062) | 3.06396926 |
| 113 | cellular glucuronidation (GO:0052695) | 3.05191422 |
| 114 | epoxygenase P450 pathway (GO:0019373) | 3.05183422 |
| 115 | alpha-amino acid catabolic process (GO:1901606) | 3.02663199 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.01996260 |
| 117 | 2-oxoglutarate metabolic process (GO:0006103) | 3.01683640 |
| 118 | tyrosine metabolic process (GO:0006570) | 2.99054543 |
| 119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98596399 |
| 120 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.98210273 |
| 121 | positive regulation of fatty acid oxidation (GO:0046321) | 2.97322398 |
| 122 | regulation of triglyceride metabolic process (GO:0090207) | 2.95446380 |
| 123 | respiratory burst (GO:0045730) | 2.94972043 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 2.94329016 |
| 125 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.94136042 |
| 126 | regulation of cholesterol metabolic process (GO:0090181) | 2.94013046 |
| 127 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.93699669 |
| 128 | fibrinolysis (GO:0042730) | 2.93479268 |
| 129 | cellular amino acid catabolic process (GO:0009063) | 2.92612970 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 2.91774049 |
| 131 | regulation of cholesterol transport (GO:0032374) | 2.91773178 |
| 132 | regulation of sterol transport (GO:0032371) | 2.91773178 |
| 133 | negative regulation of lipase activity (GO:0060192) | 2.91440941 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91206385 |
| 135 | response to host immune response (GO:0052572) | 2.91206385 |
| 136 | lipid homeostasis (GO:0055088) | 2.91003423 |
| 137 | fatty acid transmembrane transport (GO:1902001) | 2.89033178 |
| 138 | cellular ketone body metabolic process (GO:0046950) | 2.88841996 |
| 139 | neutrophil activation (GO:0042119) | 2.88400349 |
| 140 | monocarboxylic acid catabolic process (GO:0072329) | 2.88149773 |
| 141 | ethanol metabolic process (GO:0006067) | 2.87924733 |
| 142 | carnitine metabolic process (GO:0009437) | 2.86674893 |
| 143 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.85800526 |
| 144 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.84531143 |
| 145 | cellular extravasation (GO:0045123) | 2.84422155 |
| 146 | type I interferon signaling pathway (GO:0060337) | 2.83982441 |
| 147 | cellular response to type I interferon (GO:0071357) | 2.83982441 |
| 148 | response to type I interferon (GO:0034340) | 2.83731622 |
| 149 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79762540 |
| 150 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.79245217 |
| 151 | thymic T cell selection (GO:0045061) | 2.78604185 |
| 152 | response to host (GO:0075136) | 2.77818429 |
| 153 | response to host defenses (GO:0052200) | 2.77818429 |
| 154 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77818429 |
| 155 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.77634270 |
| 156 | megakaryocyte development (GO:0035855) | 2.77048669 |
| 157 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.75584903 |
| 158 | negative regulation of interleukin-12 production (GO:0032695) | 2.74173125 |
| 159 | response to interleukin-15 (GO:0070672) | 2.73807448 |
| 160 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73237814 |
| 161 | regulation of mast cell degranulation (GO:0043304) | 2.71603163 |
| 162 | granulocyte activation (GO:0036230) | 2.70329621 |
| 163 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.65398474 |
| 164 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.64600270 |
| 165 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64012094 |
| 166 | regulation of leukocyte degranulation (GO:0043300) | 2.63778379 |
| 167 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.63542478 |
| 168 | T cell selection (GO:0045058) | 2.62763091 |
| 169 | cellular response to interleukin-15 (GO:0071350) | 2.61394577 |
| 170 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.60373685 |
| 171 | regulation of T cell tolerance induction (GO:0002664) | 2.58439286 |
| 172 | positive regulation of interferon-alpha production (GO:0032727) | 2.57611303 |
| 173 | B cell receptor signaling pathway (GO:0050853) | 2.57133960 |
| 174 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.55900115 |
| 175 | response to thyroid hormone (GO:0097066) | 2.55474263 |
| 176 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.53925435 |
| 177 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53174648 |
| 178 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.53046359 |
| 179 | reactive oxygen species biosynthetic process (GO:1903409) | 2.52670437 |
| 180 | regulation of antigen processing and presentation (GO:0002577) | 2.52147141 |
| 181 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52083443 |
| 182 | response to laminar fluid shear stress (GO:0034616) | 2.52055921 |
| 183 | response to muramyl dipeptide (GO:0032495) | 2.51602492 |
| 184 | regulation of cellular amide metabolic process (GO:0034248) | 2.50935038 |
| 185 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.49832528 |
| 186 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.47904692 |
| 187 | positive thymic T cell selection (GO:0045059) | 2.46900523 |
| 188 | negative regulation of T cell mediated immunity (GO:0002710) | 2.45591828 |
| 189 | macrophage activation (GO:0042116) | 2.45276875 |
| 190 | cellular response to virus (GO:0098586) | 2.45255285 |
| 191 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.43758248 |
| 192 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.42633331 |
| 193 | regulation of defense response to virus by virus (GO:0050690) | 2.41535358 |
| 194 | mast cell activation (GO:0045576) | 2.41289951 |
| 195 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.40579251 |
| 196 | regulation of tolerance induction (GO:0002643) | 2.40386650 |
| 197 | negative regulation of innate immune response (GO:0045824) | 2.38473714 |
| 198 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.38273086 |
| 199 | dendritic cell chemotaxis (GO:0002407) | 2.35182338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.11181459 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.34664585 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.96887110 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.91465657 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.34735946 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.31964849 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.39108127 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.36269743 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.77822091 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.75274376 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63989436 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.53105470 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35610330 |
| 14 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29608072 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.24763027 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19807361 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08941804 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07458166 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.03684871 |
| 20 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02447507 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97701284 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.92211051 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91707880 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83814920 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82162741 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80239267 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.79519737 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73569176 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71003012 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70483469 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67928677 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64732734 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64070339 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63113195 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.62061812 |
| 36 | * MAF_26560356_Chip-Seq_TH2_Human | 1.61754313 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60287790 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54332439 |
| 39 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53073812 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51460002 |
| 41 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.47749378 |
| 42 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.46889864 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.44424235 |
| 44 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43947467 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41436952 |
| 46 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41044765 |
| 47 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40232044 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38614443 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38237197 |
| 50 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38163124 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37959187 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37879369 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36695505 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36308923 |
| 55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35641747 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33718633 |
| 57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33369326 |
| 58 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33237703 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33080018 |
| 60 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32559817 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31911178 |
| 62 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31649892 |
| 63 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30731141 |
| 64 | * MYB_26560356_Chip-Seq_TH1_Human | 1.28929853 |
| 65 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28883570 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28456323 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28284011 |
| 68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27014204 |
| 69 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26969035 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26866239 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26427147 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25636632 |
| 73 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25480468 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.24988710 |
| 75 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24824667 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24807075 |
| 77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24503502 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23455711 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23064980 |
| 80 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22982678 |
| 81 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21809955 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20675877 |
| 83 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18983179 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17053589 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16353300 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14519537 |
| 87 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14131802 |
| 88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13097592 |
| 89 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11539825 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09394206 |
| 91 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09045851 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09038357 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08772500 |
| 94 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08281086 |
| 95 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08019975 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07853260 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07447483 |
| 98 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06623546 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06009547 |
| 100 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04275215 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04203982 |
| 102 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04162518 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04021794 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03824163 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03484073 |
| 106 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03264429 |
| 107 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02224734 |
| 108 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.00242658 |
| 109 | * MAF_26560356_Chip-Seq_TH1_Human | 0.99994937 |
| 110 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99407369 |
| 111 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98534968 |
| 112 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.98477951 |
| 113 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98404936 |
| 114 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97939724 |
| 115 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97798779 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97440026 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96314739 |
| 118 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96310785 |
| 119 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96068242 |
| 120 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95986246 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95343614 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94213147 |
| 123 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93740055 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92264358 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92208888 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91433913 |
| 127 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91325260 |
| 128 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90247574 |
| 129 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88779635 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88706032 |
| 131 | * MYC_22102868_ChIP-Seq_BL_Human | 0.86929248 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84088209 |
| 133 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.82874816 |
| 134 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81591208 |
| 135 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80703655 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79823909 |
| 137 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79625337 |
| 138 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79625337 |
| 139 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78013802 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77268349 |
| 141 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76959784 |
| 142 | * P68_20966046_ChIP-Seq_HELA_Human | 0.76648002 |
| 143 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76119317 |
| 144 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76119317 |
| 145 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75965964 |
| 146 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75821918 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75592681 |
| 148 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.74775611 |
| 149 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.74608194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.73545439 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.43224989 |
| 3 | MP0005365_abnormal_bile_salt | 4.30614157 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.15313863 |
| 5 | MP0009840_abnormal_foam_cell | 3.52098112 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.36267152 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.00091575 |
| 8 | MP0003252_abnormal_bile_duct | 2.95937792 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.90569047 |
| 10 | MP0008995_early_reproductive_senescence | 2.79222360 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.71138251 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.66147109 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.64517076 |
| 14 | MP0005671_abnormal_response_to | 2.55661246 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.52698421 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.51546073 |
| 17 | MP0009785_altered_susceptibility_to | 2.29330003 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.17450601 |
| 19 | MP0001800_abnormal_humoral_immune | 2.16145333 |
| 20 | MP0005083_abnormal_biliary_tract | 2.08268627 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.01967966 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.01362423 |
| 23 | MP0000609_abnormal_liver_physiology | 1.98193487 |
| 24 | MP0005332_abnormal_amino_acid | 1.94092995 |
| 25 | * MP0002420_abnormal_adaptive_immunity | 1.89245188 |
| 26 | * MP0002723_abnormal_immune_serum | 1.88327484 |
| 27 | * MP0001819_abnormal_immune_cell | 1.87248862 |
| 28 | MP0002796_impaired_skin_barrier | 1.85015741 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.82483309 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.81414173 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.81176620 |
| 32 | MP0005670_abnormal_white_adipose | 1.75084128 |
| 33 | MP0008260_abnormal_autophagy | 1.71742825 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.70431549 |
| 35 | MP0004381_abnormal_hair_follicle | 1.64851140 |
| 36 | MP0002132_abnormal_respiratory_system | 1.63777494 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.63508473 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.60045976 |
| 39 | MP0002254_reproductive_system_inflammat | 1.57923067 |
| 40 | MP0003195_calcinosis | 1.54176090 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.52638511 |
| 42 | MP0000858_altered_metastatic_potential | 1.47311020 |
| 43 | * MP0002398_abnormal_bone_marrow | 1.46838054 |
| 44 | MP0003828_pulmonary_edema | 1.46765123 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.45306656 |
| 46 | MP0005666_abnormal_adipose_tissue | 1.45180197 |
| 47 | * MP0000716_abnormal_immune_system | 1.45096179 |
| 48 | MP0005451_abnormal_body_composition | 1.45066366 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.42389782 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.41817080 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.39963432 |
| 52 | MP0002405_respiratory_system_inflammati | 1.38663872 |
| 53 | MP0004947_skin_inflammation | 1.36271611 |
| 54 | MP0003436_decreased_susceptibility_to | 1.35825558 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.33435338 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.31311137 |
| 57 | MP0005275_abnormal_skin_tensile | 1.31297183 |
| 58 | MP0004858_abnormal_nervous_system | 1.28038943 |
| 59 | MP0004130_abnormal_muscle_cell | 1.25293565 |
| 60 | MP0002060_abnormal_skin_morphology | 1.24582418 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.24026746 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.23295844 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.21277069 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.20875679 |
| 65 | MP0001851_eye_inflammation | 1.20827141 |
| 66 | * MP0002429_abnormal_blood_cell | 1.20435036 |
| 67 | MP0004264_abnormal_extraembryonic_tissu | 1.20266556 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.17777507 |
| 69 | MP0002722_abnormal_immune_system | 1.14984512 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14705163 |
| 71 | MP0009278_abnormal_bone_marrow | 1.11108270 |
| 72 | MP0003303_peritoneal_inflammation | 1.10064749 |
| 73 | MP0002971_abnormal_brown_adipose | 1.07262903 |
| 74 | MP0004510_myositis | 1.06190811 |
| 75 | MP0005409_darkened_coat_color | 1.05907997 |
| 76 | MP0003868_abnormal_feces_composition | 1.05043083 |
| 77 | MP0005310_abnormal_salivary_gland | 1.03653257 |
| 78 | MP0005023_abnormal_wound_healing | 1.03368655 |
| 79 | MP0000598_abnormal_liver_morphology | 1.02943584 |
| 80 | MP0005501_abnormal_skin_physiology | 1.02405321 |
| 81 | MP0000490_abnormal_crypts_of | 1.02042554 |
| 82 | MP0005375_adipose_tissue_phenotype | 1.01451158 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.00060233 |
| 84 | MP0008469_abnormal_protein_level | 0.98672269 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.97688710 |
| 86 | MP0000604_amyloidosis | 0.97523321 |
| 87 | MP0006082_CNS_inflammation | 0.97521365 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.96231328 |
| 89 | MP0001216_abnormal_epidermal_layer | 0.95529551 |
| 90 | MP0002396_abnormal_hematopoietic_system | 0.90362554 |
| 91 | MP0001764_abnormal_homeostasis | 0.89545827 |
| 92 | MP0009764_decreased_sensitivity_to | 0.88615881 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.88152873 |
| 94 | MP0000678_abnormal_parathyroid_gland | 0.88130128 |
| 95 | MP0000343_altered_response_to | 0.87912873 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.87670868 |
| 97 | MP0005334_abnormal_fat_pad | 0.87073734 |
| 98 | MP0009115_abnormal_fat_cell | 0.85665725 |
| 99 | MP0008004_abnormal_stomach_pH | 0.84288902 |
| 100 | MP0001873_stomach_inflammation | 0.84011636 |
| 101 | MP0001756_abnormal_urination | 0.82471016 |
| 102 | MP0005390_skeleton_phenotype | 0.82248160 |
| 103 | MP0003186_abnormal_redox_activity | 0.82064332 |
| 104 | MP0003448_altered_tumor_morphology | 0.81388072 |
| 105 | MP0009763_increased_sensitivity_to | 0.80899992 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.80579729 |
| 107 | MP0001663_abnormal_digestive_system | 0.80470054 |
| 108 | MP0000579_abnormal_nail_morphology | 0.80448884 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.79360040 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.78598342 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.78253961 |
| 112 | MP0000685_abnormal_immune_system | 0.77221046 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.77005928 |
| 114 | MP0001881_abnormal_mammary_gland | 0.76316639 |
| 115 | MP0000249_abnormal_blood_vessel | 0.75128451 |
| 116 | MP0002166_altered_tumor_susceptibility | 0.73948933 |
| 117 | MP0003786_premature_aging | 0.72908351 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.72642740 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.72642740 |
| 120 | MP0009642_abnormal_blood_homeostasis | 0.72331851 |
| 121 | MP0003724_increased_susceptibility_to | 0.71283237 |
| 122 | MP0003011_delayed_dark_adaptation | 0.70264531 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.70122952 |
| 124 | MP0001243_abnormal_dermal_layer | 0.69880266 |
| 125 | MP0000377_abnormal_hair_follicle | 0.69579181 |
| 126 | MP0004883_abnormal_blood_vessel | 0.69362124 |
| 127 | MP0005076_abnormal_cell_differentiation | 0.69222131 |
| 128 | MP0005448_abnormal_energy_balance | 0.68221988 |
| 129 | MP0005387_immune_system_phenotype | 0.67652999 |
| 130 | MP0001790_abnormal_immune_system | 0.67652999 |
| 131 | MP0005025_abnormal_response_to | 0.66348976 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.65067629 |
| 133 | MP0002419_abnormal_innate_immunity | 0.64687954 |
| 134 | MP0001849_ear_inflammation | 0.64286968 |
| 135 | MP0003075_altered_response_to | 0.64156708 |
| 136 | MP0003866_abnormal_defecation | 0.62667096 |
| 137 | MP0009931_abnormal_skin_appearance | 0.62454810 |
| 138 | MP0003045_fibrosis | 0.61595700 |
| 139 | MP0002970_abnormal_white_adipose | 0.61253594 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.60435010 |
| 141 | MP0002168_other_aberrant_phenotype | 0.59561634 |
| 142 | MP0005166_decreased_susceptibility_to | 0.57914421 |
| 143 | MP0000477_abnormal_intestine_morphology | 0.57589848 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.57555498 |
| 145 | MP0000467_abnormal_esophagus_morphology | 0.57261776 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.56682166 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.56472788 |
| 148 | MP0010678_abnormal_skin_adnexa | 0.54945378 |
| 149 | MP0008961_abnormal_basal_metabolism | 0.54736757 |
| 150 | MP0009765_abnormal_xenobiotic_induced | 0.54605687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 5.23582610 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.05127670 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.93645085 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.58692048 |
| 5 | Duplicated collecting system (HP:0000081) | 4.55297351 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.45208431 |
| 7 | Complement deficiency (HP:0004431) | 4.28832828 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.25450965 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.19552632 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.90736279 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.88693702 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.84046901 |
| 13 | Abnormality of the renal collecting system (HP:0004742) | 3.83367386 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.78351816 |
| 15 | Hyperglycinuria (HP:0003108) | 3.67651761 |
| 16 | Myocardial infarction (HP:0001658) | 3.63344854 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.61194972 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 3.54376775 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.49070733 |
| 20 | Oral leukoplakia (HP:0002745) | 3.48764697 |
| 21 | Epidermoid cyst (HP:0200040) | 3.47343130 |
| 22 | Ureteral duplication (HP:0000073) | 3.46334082 |
| 23 | Hyperammonemia (HP:0001987) | 3.45966817 |
| 24 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.41710727 |
| 25 | Abnormality of complement system (HP:0005339) | 3.38116420 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.36785327 |
| 27 | Myositis (HP:0100614) | 3.34142486 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33432909 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.33432909 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.32480272 |
| 31 | Orchitis (HP:0100796) | 3.22742076 |
| 32 | Reticulocytopenia (HP:0001896) | 3.20395292 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.19600153 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.19390830 |
| 35 | Ketosis (HP:0001946) | 3.17780461 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.16580786 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.16308989 |
| 38 | Fat malabsorption (HP:0002630) | 3.09210955 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.06763598 |
| 40 | Joint hemorrhage (HP:0005261) | 3.02188678 |
| 41 | Hyperglycinemia (HP:0002154) | 3.01598588 |
| 42 | Right ventricular cardiomyopathy (HP:0011663) | 2.98957563 |
| 43 | Hypochromic anemia (HP:0001931) | 2.93683299 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.89520505 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.88991671 |
| 46 | Cellulitis (HP:0100658) | 2.83727019 |
| 47 | Gingivitis (HP:0000230) | 2.82033940 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.81694018 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.79515589 |
| 50 | Optic neuritis (HP:0100653) | 2.79515589 |
| 51 | Granulocytopenia (HP:0001913) | 2.77843282 |
| 52 | Chromsome breakage (HP:0040012) | 2.76458461 |
| 53 | Urticaria (HP:0001025) | 2.76378791 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.75157818 |
| 55 | Increased IgM level (HP:0003496) | 2.74361334 |
| 56 | Meningitis (HP:0001287) | 2.73279047 |
| 57 | Malnutrition (HP:0004395) | 2.70426677 |
| 58 | Abnormality of proline metabolism (HP:0010907) | 2.70129414 |
| 59 | Hydroxyprolinuria (HP:0003080) | 2.70129414 |
| 60 | Abnormality of DNA repair (HP:0003254) | 2.68946114 |
| 61 | Aplastic anemia (HP:0001915) | 2.67521502 |
| 62 | Vasculitis (HP:0002633) | 2.67304831 |
| 63 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.65876560 |
| 64 | Enlarged epiphyses (HP:0010580) | 2.65010465 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.64786992 |
| 66 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.61063648 |
| 67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.59954279 |
| 68 | Eosinophilia (HP:0001880) | 2.58935276 |
| 69 | Obstructive lung disease (HP:0006536) | 2.58372275 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58372275 |
| 71 | Joint swelling (HP:0001386) | 2.53774522 |
| 72 | Recurrent skin infections (HP:0001581) | 2.52959220 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.52076429 |
| 74 | Esophageal varix (HP:0002040) | 2.51617460 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.50637190 |
| 76 | Ketoacidosis (HP:0001993) | 2.49549671 |
| 77 | Ileus (HP:0002595) | 2.48881998 |
| 78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45355436 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44250264 |
| 80 | Skin nodule (HP:0200036) | 2.42853603 |
| 81 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41996921 |
| 82 | Abnormality of T cells (HP:0002843) | 2.41861411 |
| 83 | Alopecia of scalp (HP:0002293) | 2.37303674 |
| 84 | Spontaneous hematomas (HP:0007420) | 2.34696196 |
| 85 | Vascular calcification (HP:0004934) | 2.34613920 |
| 86 | Pustule (HP:0200039) | 2.32340927 |
| 87 | Duplication of thumb phalanx (HP:0009942) | 2.30274878 |
| 88 | Flattened epiphyses (HP:0003071) | 2.30185850 |
| 89 | Recurrent viral infections (HP:0004429) | 2.29171347 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.27746951 |
| 91 | Peritonitis (HP:0002586) | 2.24681237 |
| 92 | Increased serum ferritin (HP:0003281) | 2.23088244 |
| 93 | T lymphocytopenia (HP:0005403) | 2.22441442 |
| 94 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21488750 |
| 95 | Glomerulonephritis (HP:0000099) | 2.21300151 |
| 96 | Gout (HP:0001997) | 2.21268227 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 2.20376309 |
| 98 | Cardiovascular calcification (HP:0011915) | 2.19965876 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 2.16779829 |
| 100 | Amyloidosis (HP:0011034) | 2.16553967 |
| 101 | Nephritis (HP:0000123) | 2.15980057 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 2.15119816 |
| 103 | Abnormality of methionine metabolism (HP:0010901) | 2.12614835 |
| 104 | Leukocytosis (HP:0001974) | 2.12594265 |
| 105 | Encephalitis (HP:0002383) | 2.12512385 |
| 106 | Spinal cord lesions (HP:0100561) | 2.10778156 |
| 107 | Syringomyelia (HP:0003396) | 2.10778156 |
| 108 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10698495 |
| 109 | Dicarboxylic aciduria (HP:0003215) | 2.10698495 |
| 110 | Hepatocellular carcinoma (HP:0001402) | 2.10679219 |
| 111 | Spastic diplegia (HP:0001264) | 2.10623199 |
| 112 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10011388 |
| 113 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10011388 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 2.09104977 |
| 115 | Colitis (HP:0002583) | 2.07454208 |
| 116 | Prolonged bleeding time (HP:0003010) | 2.06962297 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.06363673 |
| 118 | Gingival bleeding (HP:0000225) | 2.06278399 |
| 119 | Eczematoid dermatitis (HP:0000976) | 2.06255042 |
| 120 | Steatorrhea (HP:0002570) | 2.06146021 |
| 121 | Inflammation of the large intestine (HP:0002037) | 2.05035054 |
| 122 | Polycythemia (HP:0001901) | 2.04607137 |
| 123 | Hemoptysis (HP:0002105) | 2.03749984 |
| 124 | Pancreatitis (HP:0001733) | 2.02150098 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 2.00969118 |
| 126 | Increased mean platelet volume (HP:0011877) | 2.00534002 |
| 127 | Late onset (HP:0003584) | 1.99186408 |
| 128 | Hyperbilirubinemia (HP:0002904) | 1.98808534 |
| 129 | Thin bony cortex (HP:0002753) | 1.98253584 |
| 130 | Thoracic kyphosis (HP:0002942) | 1.97684613 |
| 131 | Axonal loss (HP:0003447) | 1.97642928 |
| 132 | Chest pain (HP:0100749) | 1.96611802 |
| 133 | Metabolic acidosis (HP:0001942) | 1.95245215 |
| 134 | Mitral stenosis (HP:0001718) | 1.94289211 |
| 135 | Osteomyelitis (HP:0002754) | 1.93894511 |
| 136 | Menorrhagia (HP:0000132) | 1.93874649 |
| 137 | Hypertriglyceridemia (HP:0002155) | 1.93716571 |
| 138 | Skin ulcer (HP:0200042) | 1.92956306 |
| 139 | Keratoconjunctivitis (HP:0001096) | 1.92924128 |
| 140 | Nasal polyposis (HP:0100582) | 1.91886508 |
| 141 | Progressive neurologic deterioration (HP:0002344) | 1.90739190 |
| 142 | Abdominal distention (HP:0003270) | 1.90382254 |
| 143 | Abnormality of the nasal mucosa (HP:0000433) | 1.90234560 |
| 144 | Protuberant abdomen (HP:0001538) | 1.89694661 |
| 145 | Rough bone trabeculation (HP:0100670) | 1.89607412 |
| 146 | Acanthocytosis (HP:0001927) | 1.89254234 |
| 147 | Cholelithiasis (HP:0001081) | 1.87923185 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.86889436 |
| 149 | Abnormal platelet volume (HP:0011876) | 1.85947200 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85758350 |
| 151 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85750672 |
| 152 | Increased IgE level (HP:0003212) | 1.84113305 |
| 153 | Abnormal gallbladder morphology (HP:0012437) | 1.83338991 |
| 154 | Stomatitis (HP:0010280) | 1.83330199 |
| 155 | Abnormality of iron homeostasis (HP:0011031) | 1.82588110 |
| 156 | Sensorimotor neuropathy (HP:0007141) | 1.81956242 |
| 157 | Hypermelanotic macule (HP:0001034) | 1.81954639 |
| 158 | Epistaxis (HP:0000421) | 1.81574440 |
| 159 | Petechiae (HP:0000967) | 1.80862398 |
| 160 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80576371 |
| 161 | Gastrointestinal stroma tumor (HP:0100723) | 1.80028838 |
| 162 | Increased connective tissue (HP:0009025) | 1.79579873 |
| 163 | Abnormality of B cell number (HP:0010975) | 1.79035527 |
| 164 | Hyperglycemia (HP:0003074) | 1.78071872 |
| 165 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77943388 |
| 166 | Mucopolysacchariduria (HP:0008155) | 1.77943388 |
| 167 | Myoglobinuria (HP:0002913) | 1.77864611 |
| 168 | Abnormality of eosinophils (HP:0001879) | 1.77695670 |
| 169 | Gangrene (HP:0100758) | 1.77678818 |
| 170 | Abnormality of T cell physiology (HP:0011840) | 1.77081803 |
| 171 | Stomach cancer (HP:0012126) | 1.76241040 |
| 172 | Leukopenia (HP:0001882) | 1.75874811 |
| 173 | Acanthosis nigricans (HP:0000956) | 1.75248396 |
| 174 | Purpura (HP:0000979) | 1.75063701 |
| 175 | Abnormal blistering of the skin (HP:0008066) | 1.74877764 |
| 176 | Lymphopenia (HP:0001888) | 1.74125163 |
| 177 | Sepsis (HP:0100806) | 1.72371633 |
| 178 | Vacuolated lymphocytes (HP:0001922) | 1.71826419 |
| 179 | Pulmonary infiltrates (HP:0002113) | 1.71277581 |
| 180 | Pigmentary retinal degeneration (HP:0001146) | 1.70846824 |
| 181 | Neonatal onset (HP:0003623) | 1.69017025 |
| 182 | Abnormality of serum amino acid levels (HP:0003112) | 1.68275674 |
| 183 | Hypoglycemic seizures (HP:0002173) | 1.67723713 |
| 184 | Abnormal gallbladder physiology (HP:0012438) | 1.66433418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.43992419 |
| 2 | TXK | 4.15607580 |
| 3 | TRIB3 | 3.98239257 |
| 4 | PRPF4B | 3.43709653 |
| 5 | SIK1 | 3.12051153 |
| 6 | FGFR4 | 2.86102119 |
| 7 | RIPK4 | 2.75765664 |
| 8 | BCKDK | 2.67811978 |
| 9 | PKN2 | 2.66795826 |
| 10 | MST1R | 2.43571816 |
| 11 | EPHB1 | 2.09193542 |
| 12 | PTK6 | 2.07531497 |
| 13 | RIPK1 | 1.97727754 |
| 14 | MAP4K1 | 1.91373599 |
| 15 | TYK2 | 1.84155952 |
| 16 | TAOK3 | 1.80117129 |
| 17 | TTN | 1.73266400 |
| 18 | TESK2 | 1.70076986 |
| 19 | EPHA2 | 1.65466756 |
| 20 | CAMK1D | 1.65193299 |
| 21 | LATS1 | 1.62332417 |
| 22 | IRAK4 | 1.58179894 |
| 23 | GRK6 | 1.50411046 |
| 24 | MAP3K10 | 1.50016875 |
| 25 | FRK | 1.44943281 |
| 26 | TNK2 | 1.42835467 |
| 27 | EEF2K | 1.42174855 |
| 28 | STK10 | 1.38047416 |
| 29 | TBK1 | 1.37664148 |
| 30 | SMG1 | 1.36700166 |
| 31 | JAK1 | 1.29663733 |
| 32 | MAP3K3 | 1.29401208 |
| 33 | BMX | 1.27696654 |
| 34 | TGFBR2 | 1.25800842 |
| 35 | LRRK2 | 1.23565710 |
| 36 | MET | 1.16095318 |
| 37 | CSK | 1.15276319 |
| 38 | MAP2K3 | 1.08731488 |
| 39 | IRAK3 | 1.08345551 |
| 40 | FGFR3 | 1.08270864 |
| 41 | JAK3 | 1.07097631 |
| 42 | MAP3K7 | 1.05241837 |
| 43 | PDGFRA | 1.05015930 |
| 44 | JAK2 | 1.04022451 |
| 45 | CAMK1G | 1.02684963 |
| 46 | MAP2K2 | 1.02591136 |
| 47 | FLT3 | 1.00977703 |
| 48 | BTK | 1.00936391 |
| 49 | ZAP70 | 1.00265922 |
| 50 | PTK2 | 0.99764368 |
| 51 | SYK | 0.97447606 |
| 52 | EPHA3 | 0.96893124 |
| 53 | MAPK11 | 0.96245161 |
| 54 | PRKD2 | 0.94017323 |
| 55 | MAP3K14 | 0.93761316 |
| 56 | FES | 0.91507606 |
| 57 | DDR2 | 0.91023948 |
| 58 | PRKAA2 | 0.90729635 |
| 59 | TESK1 | 0.88790028 |
| 60 | NEK9 | 0.86253702 |
| 61 | BLK | 0.85546650 |
| 62 | PRKG2 | 0.85200127 |
| 63 | ICK | 0.82818652 |
| 64 | CDK6 | 0.82667193 |
| 65 | CDC42BPA | 0.82463667 |
| 66 | MARK2 | 0.82221617 |
| 67 | IKBKE | 0.82181943 |
| 68 | ERBB4 | 0.80535186 |
| 69 | LCK | 0.80076440 |
| 70 | MAP3K11 | 0.79925657 |
| 71 | LYN | 0.79727328 |
| 72 | TAOK1 | 0.77988517 |
| 73 | TAOK2 | 0.77139476 |
| 74 | CDK12 | 0.76052899 |
| 75 | MST4 | 0.75888114 |
| 76 | ITK | 0.75655920 |
| 77 | MTOR | 0.75468607 |
| 78 | INSRR | 0.73396591 |
| 79 | DYRK1B | 0.73178655 |
| 80 | MAPK12 | 0.72028191 |
| 81 | PIK3CG | 0.70605481 |
| 82 | SIK3 | 0.70568769 |
| 83 | FGR | 0.69467021 |
| 84 | MAP3K6 | 0.69269015 |
| 85 | TRPM7 | 0.69014334 |
| 86 | CSF1R | 0.68584353 |
| 87 | MAP3K2 | 0.63474690 |
| 88 | PAK4 | 0.63030621 |
| 89 | KSR2 | 0.62913878 |
| 90 | PDPK1 | 0.62231858 |
| 91 | GSK3A | 0.61857123 |
| 92 | FER | 0.61361632 |
| 93 | STK3 | 0.59898670 |
| 94 | MAP3K1 | 0.57613288 |
| 95 | MATK | 0.57097521 |
| 96 | DMPK | 0.54862322 |
| 97 | CHUK | 0.54561741 |
| 98 | HCK | 0.53397247 |
| 99 | IRAK2 | 0.53152924 |
| 100 | MAPKAPK3 | 0.52827003 |
| 101 | FGFR2 | 0.52277527 |
| 102 | LMTK2 | 0.51187149 |
| 103 | PRKAA1 | 0.48569162 |
| 104 | IKBKB | 0.47546138 |
| 105 | FYN | 0.47412698 |
| 106 | PDGFRB | 0.46392944 |
| 107 | RET | 0.46112747 |
| 108 | MAP2K1 | 0.45489635 |
| 109 | MAPKAPK2 | 0.45364165 |
| 110 | KDR | 0.45149264 |
| 111 | PRKCH | 0.42129356 |
| 112 | MAP3K8 | 0.41815386 |
| 113 | PRKD1 | 0.41587592 |
| 114 | PIM1 | 0.41264497 |
| 115 | KIT | 0.40635229 |
| 116 | PAK2 | 0.40308191 |
| 117 | RPS6KL1 | 0.40089482 |
| 118 | RPS6KC1 | 0.40089482 |
| 119 | PIM2 | 0.39752214 |
| 120 | HIPK2 | 0.39657750 |
| 121 | PDK1 | 0.39538534 |
| 122 | RPS6KA2 | 0.39489818 |
| 123 | SGK3 | 0.38910322 |
| 124 | PIK3CA | 0.38233212 |
| 125 | YES1 | 0.38218051 |
| 126 | MAPK7 | 0.37981817 |
| 127 | EGFR | 0.37854213 |
| 128 | EPHB2 | 0.37797818 |
| 129 | SIK2 | 0.36865650 |
| 130 | RPS6KA4 | 0.36142029 |
| 131 | ERBB2 | 0.35193822 |
| 132 | IRAK1 | 0.34912876 |
| 133 | SGK1 | 0.34360095 |
| 134 | RPS6KA6 | 0.33980263 |
| 135 | FGFR1 | 0.33814473 |
| 136 | MAP3K13 | 0.33580694 |
| 137 | NLK | 0.33297862 |
| 138 | MAP2K6 | 0.31649691 |
| 139 | STK38 | 0.23631048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31763069 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.95371413 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95321176 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56586891 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56047889 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.53293384 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39724462 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36529132 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.28119244 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27760325 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.23648351 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.22608982 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.11573229 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09689945 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06680033 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06318371 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.05481630 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05256163 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.01299426 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92630676 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88294921 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88049549 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85113480 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83332862 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81517290 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.81035615 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.70920446 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68933553 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68489482 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67746743 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65830053 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.65183737 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63193497 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61343567 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57904694 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54261102 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.53177365 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.52874800 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48128287 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45239637 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.43684140 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41295445 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39117522 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.32957898 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31092572 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30425320 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28812965 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28506150 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28336318 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26843064 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26840113 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26659469 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.24488464 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23962068 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22049639 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21771721 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21582054 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20842328 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20369021 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19185108 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17849127 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17167271 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16522079 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15132055 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14559089 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14259943 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14045059 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 1.14003711 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12541614 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11815501 |
| 71 | Measles_Homo sapiens_hsa05162 | 1.11305573 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10012000 |
| 73 | Asthma_Homo sapiens_hsa05310 | 1.09948741 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02660355 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02375492 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00629235 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00013923 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.98559071 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98229183 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.97212542 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95842947 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95762245 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94436866 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92451581 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91660437 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88097262 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.87039289 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86762331 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86265163 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.85579994 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.81775356 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81688230 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79323921 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78968069 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.78149554 |
| 96 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77667448 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77078822 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76438341 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74330049 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74055937 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73445330 |
| 102 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72813783 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72401008 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72337374 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70899983 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69620178 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68667902 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68075043 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66149550 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64122063 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.63834877 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60615613 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56047335 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55415438 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54839549 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54294647 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53182560 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52902572 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52601692 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.52573147 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51994658 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51485041 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51345045 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.51033214 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50666325 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50014157 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49397145 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49312448 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48661370 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47329141 |
| 131 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42376676 |
| 132 | Shigellosis_Homo sapiens_hsa05131 | 0.42329388 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41671657 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41193497 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40837647 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40750191 |
| 137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40528525 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.40112037 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39665583 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39400458 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38560584 |
| 142 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35496398 |
| 143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35098639 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34618015 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.32847512 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.32596807 |
| 147 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31621671 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.31192759 |
| 149 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30304901 |
| 150 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24297749 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23293801 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22732181 |
| 153 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21981601 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.20770758 |
| 155 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20724561 |
| 156 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.19825673 |
| 157 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19422779 |
| 158 | Pertussis_Homo sapiens_hsa05133 | 0.15975804 |
| 159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15162738 |
| 160 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13789961 |
| 161 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.11692128 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11261409 |
| 163 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.09892636 |

